Mihalič, Filip http://orcid.org/0000-0002-6840-2319
Benz, Caroline http://orcid.org/0000-0002-5166-3598
Kassa, Eszter
Lindqvist, Richard
Simonetti, Leandro http://orcid.org/0000-0003-1283-9770
Inturi, Raviteja
Aronsson, Hanna
Andersson, Eva
Chi, Celestine N.
Davey, Norman E.
Överby, Anna K. http://orcid.org/0000-0001-6553-0940
Jemth, Per http://orcid.org/0000-0003-1516-7228
Ivarsson, Ylva http://orcid.org/0000-0002-7081-3846
Funding for this research was provided by:
Stiftelsen för Strategisk Forskning (SB16-0039)
Vetenskapsrådet (2020-03380, 2018-05851)
Cancer Research UK (C68484/A28159)
Article History
Received: 2 November 2022
Accepted: 30 August 2023
First Online: 13 September 2023
Competing interests
: A patent application for protection of cell-penetrating peptides targeting Nsp9 and Nsp16 has been submitted under No. 2251153-9 and is currently under consideration (F.M., C.B., E.K., R.L., A.K.Ö., P.J., and Y.I.). The remaining authors declare no competing interests.